Existe-t-il des manifestations extradigestives de l’infection à Helicobacter pylori ?
Tài liệu tham khảo
Israel, 2006, The role of persistence in Helicobacter pylori pathogenesis, Curr Opin Gastroenterol, 22, 3, 10.1097/01.mog.0000194790.51714.f0
De Korwin JD, Frédéric M. Les gastrites chroniques. EMC Gastro-entérologie 2003;9-017-A-10.
De Korwin, 2006, La gastrite à Helicobacter pylori, une pathologie frontière, Rev Med Interne, 27, S61, 10.1016/j.revmed.2006.03.021
Goodman, 2006, Extragastric diseases associated with Helicobacter pylori infection, Curr Gastroenterol Rep, 8, 458, 10.1007/s11894-006-0035-3
Solnick, 2006, Extragastric manifestations of Helicobacter pylori infection and other Helicobacter species, Helicobacter, 11, 46, 10.1111/j.1478-405X.2006.00430.x
Franchini, 2006, Helicobacter pylori-associated immune thrombocytopenia, Platelets, 17, 71, 10.1080/09537100500438057
Jackson, 2005, Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature, Am J Hematol, 78, 142, 10.1002/ajh.20250
Kohda, 2002, Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura, Br J Haematol, 118, 584, 10.1046/j.1365-2141.2002.03612.x
Hashino, 2003, Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori, Int J Hematol, 77, 188, 10.1007/BF02983220
Sato, 2004, Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura, Arch Intern Med, 164, 1904, 10.1001/archinte.164.17.1904
Takahashi, 2004, Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura, Br J Haematol, 124, 91, 10.1046/j.1365-2141.2003.04735.x
Fujimura, 2005, Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan, Int J Hematol, 81, 162, 10.1532/IJH97.04146
Inaba, 2005, Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan, Eur J Clin Invest, 35, 214, 10.1111/j.1365-2362.2005.01471.x
Kodama, 2007, Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura, Helicobacter, 12, 36, 10.1111/j.1523-5378.2007.00477.x
Gasbarrini, 1998, Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori, Lancet, 352, 878, 10.1016/S0140-6736(05)60004-9
Emilia, 2001, Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura, Blood, 97, 812, 10.1182/blood.V97.3.812
Jarque, 2001, Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura, Br J Haematol, 115, 1002, 10.1046/j.1365-2141.2001.03194.x
Michel, 2002, Autoimmune thrombocytopenic purpura and Helicobacter pylori infection, Arch Intern Med, 162, 1033, 10.1001/archinte.162.9.1033
Kurtoglu, 2004, Helicobacter pylori infection in patients with autoimmune thrombocytopenic purpura, World J Gastroenterol, 10, 2113, 10.3748/wjg.v10.i14.2113
Michel, 2004, Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura?, Blood, 103, 890, 10.1182/blood-2003-03-0900
Stasi, 2005, Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura, Am J Med, 118, 414, 10.1016/j.amjmed.2004.09.014
Veneri, 2005, Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment, Platelets, 16, 307, 10.1080/09537100400028685
Veneri, 2005, High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: a long-term follow-up study, Platelets, 16, 117, 10.1080/09537100400015153
Suvajdzic, 2006, Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura, Platelets, 17, 227, 10.1080/09537100500462487
McCrae, 2004, Helicobacter pylori and ITP: many questions, few answers, Blood, 103, 752, 10.1182/blood-2003-11-3886
Ishiyama, 2006, Clonally expanded T-cells in the peripheral blood of patients with idiopathic thrombocytopenic purpura and Helicobacter pylori infection, Int J Hematol, 83, 147, 10.1532/IJH97.05119
Malfertheiner, 2007, Current concepts in the management of Helicobacter pylori infection – The Maastricht III Consensus Report, Gut, 56, 772, 10.1136/gut.2006.101634
Chey, 2007, American College of Gastroenterology guideline on management of Helicobacter pylori infection, Am J Gastroenterol, 102, 1, 10.1111/j.1572-0241.2007.01393.x
DuBois, 2005, Iron-deficiency anaemia and Helicobacter pylori infection: a review of the evidence, Am J Gastroenterol, 100, 453, 10.1111/j.1572-0241.2005.30252.x
Cardenas, 2006, Iron deficiency and Helicobacter pylori infection in the United States, Am J Epidemiol, 163, 127, 10.1093/aje/kwj018
Nahon, 2003, Helicobacter pylori-associated chronic gastritis and unexplained iron deficiency anemia: a reliable association?, Helicobacter, 8, 573, 10.1111/j.1523-5378.2003.00184.x
Annibale, 1999, Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis, Ann Intern Med, 131, 668, 10.7326/0003-4819-131-9-199911020-00006
Gaig, 2002, Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebo-controlled double blind study, Allergol Immunopathol, 30, 255, 10.1016/S0301-0546(02)79133-7
Federman, 2003, The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria, J Am Acad Dermatol, 49, 861, 10.1016/S0190-9622(03)00846-6
Moreira, 2003, Is Helicobacter pylori infection associated with chronic idiopathic urticaria?, Allergol Immunopathol, 31, 209, 10.1157/13050378
Sakurane, 2002, Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients, J Dermatol, 29, 23, 10.1111/j.1346-8138.2002.tb00160.x
Galadari, 2006, The role of Helicobacter pylori in urticaria and atopic dermatitis, Skinmed, 5, 172, 10.1111/j.1540-9740.2006.04646.x
Witherell, 2003, C-reactive protein, Helicobacter pylori, Chlamydiae pneumoniae, cytomegalovirus and risk for myocardial infarction, Ann Epidemiol, 13, 170, 10.1016/S1047-2797(02)00276-4
Ridker, 2001, A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men, Ann Intern Med, 135, 184, 10.7326/0003-4819-135-3-200108070-00010
Preusch, 2004, Association between cerebral ischemia and cytotoxin-associated gene-A-bearing strains of Helicobacter pylori, Stroke, 35, 1800, 10.1161/01.STR.0000131751.35926.48
Singh, 2002, Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease, Heart, 88, 43, 10.1136/heart.88.1.43
Whincup, 2000, Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men, Circulation, 101, 1647, 10.1161/01.CIR.101.14.1647
Stone, 2001, Ischaemic heart disease and Cag A strains of Helicobacter pylori in the Caerphilly heart disease study, Heart, 86, 506, 10.1136/heart.86.5.506
Mayr, 2003, Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study, Stroke, 34, 610, 10.1161/01.STR.0000058481.82639.EF
Markus, 2002, Helicobacter pylori infection, the cytotoxin gene A strain and carotid artery intima-media thickness, J Cardiovasc Risk, 9, 1, 10.1097/00043798-200202000-00001
Diomedi, 2004, Cag-A-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke, Neurology, 63, 800, 10.1212/01.WNL.0000138025.82419.80
Fraser, 2003, Helicobacter pylori, Chlamydia pneumoniae and myocardial infarction, Intern Med J, 33, 267, 10.1046/j.1445-5994.2003.00349.x
Lindsberg, 2003, Inflammation and infections as risk factors for ischemic stroke, Stroke, 34, 2518, 10.1161/01.STR.0000089015.51603.CC
Kanbay, 2005, Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels?, Dig Dis Sci, 50, 1228, 10.1007/s10620-005-2764-9
Gabrielli, 2004, CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke, Eur Heart J, 25, 64, 10.1016/j.ehj.2003.10.004
Figueiredo, 2002, Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma, J Natl Cancer Inst, 94, 1662, 10.1093/jnci/94.22.1680
Lamb, 2003, Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation, Atherosclerosis, 167, 177, 10.1016/S0021-9150(02)00301-5
Franceschi, 2002, Cross-reactivity of Anti-CagA antibodies with vascular wall antigens, Circulation, 106, 430, 10.1161/01.CIR.0000024100.90140.19
Stone, 2002, Effect of treatment for Chlamydiae pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and unstable Angina (STAMINA), Circulation, 106, 1219, 10.1161/01.CIR.0000027820.66786.CF
Andraw, 2005, Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials, JAMA, 293, 2641, 10.1001/jama.293.21.2641
Scharnagl, 2004, Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol, Am J Cardiol, 93, 219, 10.1016/j.amjcard.2003.09.045
Gasbarrini, 1996, Association of Helicobacter pylori infection with primary Raynaud phenomenon, Lancet, 348, 966, 10.1016/S0140-6736(05)65386-X
Savarino, 2000, No evidence of an association between Helicobacter pylori infection and Raynaud phenomenon, Scand J Gastroenterol, 35, 1251, 10.1080/003655200453575
Sulli, 2000, Lack of correlation between gastric Helicobacter pylori infection and primary or secondary Raynaud's phenomenon in patients with systemic sclerosis, J Rheumatol, 27, 1820
de Korwin, 2004, Raynaud's phenomenon is not associated with Helicobacter pylori infection, Gut, 49, A202
Herve, 2006, Helicobacter pylori prevalence in Raynaud's disease, Rev Med Interne, 27, 736
Kanbay, 2007, Helicobacter pylori infection as a possible risk factor for respiratory system disease/a review of the literature, Respir Med, 101, 203, 10.1016/j.rmed.2006.04.022
Weller, 2005, Role of chronic infection and inflammation in the gastrointestinal tract in the aetiology and pathogenesis of idiopathic parkinsonism. Part 3: predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody profile, Helicobacter, 10, 288, 10.1111/j.1523-5378.2005.00329.x
Schulz, 2006, Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denominator, Med Hypotheses, 66, 1222, 10.1016/j.mehy.2004.12.033
Pierantozzi, 2006, Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations, Neurology, 66, 1824, 10.1212/01.wnl.0000221672.01272.ba
Centanni, 2006, Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis, N Engl J Med, 354, 1787, 10.1056/NEJMoa043903
Isomoto, 2005, Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans, Am J Gastroenterol, 100, 1711, 10.1111/j.1572-0241.2005.41492.x
Tatsuguchi, 2004, Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa, Am J Gastroenterol, 99, 2121, 10.1111/j.1572-0241.2004.30291.x